NCT05070247 2026-01-22
A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Takeda
Phase 1/2 Terminated
Takeda
Checkpoint Therapeutics, Inc.
Calithera Biosciences, Inc
Genprex, Inc.
Peking University First Hospital
National Institutes of Health Clinical Center (CC)
University of Arizona
Peking University First Hospital